Pegasus Tech Ventures will help the spark plug and ceramic manufacturer back global entrepreneurs working on healthcare, distributed generation and automotive innovation.

GV returned to reinvest in small molecule drug developer Ventus Therapeutics having backed its $60m series A round almost a year ago.

The Pierre Fabre-backed antibody therapy developer has closed a series A round featuring new and founding investors.

UC Berkeley's DNA-editing technology spinout has raised $10m from RA Capital in addition to the $65m it pocketed in November.

The Yitu-backed cancer therapy developer has secured an eight-digit dollar amount after closing a similarly sized series B round four months ago.

RA Capital Management has led a series B round for the UW-linked vaccine developer, which had raised $51m in a series A 18 months ago.

Sanofi Ventures reinvested in the vaccine developer through a series B round that followed a $51m series A 18 months ago.

Mayo Clinic-backed Pendulum near doubled its total funding in a round that will support increased manufacturing of its lead probiotic product.

The DNA-editing technology developer has raised $10m in addition to the $65m it pulled in from investors including Leaps by Bayer in November.

Lilly Asia Ventures contributed to a $55m round that will support work on Nucleix's early-stage lung cancer biopsy.